Spinal fractures from osteoporosis cause many to lose their independence. Industry veteran Dom Messerli has a better way of fixing the problem than the risky practice of injecting liquid epoxy into the spine. Using engineered human bone, Lenoss Medical is offering a treatment that is safer, effective and easier to administer than the current standard.

Highlights:

·      Sal Daher, CFA Introduces Dom Messerli, Founder of Lenoss Medical ·      “Many times, the patients lose their independence when those fractures happen.” ·      Current Standard of Care is to Inject Liquid Epoxy into the Spine – What Could Go Wrong? ·      Liquid Epoxy Can Leak into Blood Vessels and Create Blockages ·      “When it's in the heart, usually what's prescribed is open heart surgery to take out the piece of cured cement out of the heart.” ·      Lenoss Medical’s Solution: Engineered Human Bone Material to Build Up the Weakened Spine ·      Grafting of Same-Species Bone Material Is Decades Old – What’s new Is Applying the Approach to Spinal Fractures ·      “...conducive for new bone formation.” ·      There’s No Donor Matching or Donor Rejection Issue Since No Living Cells Are Implanted ·      Lenoss Medical Was the Subject of Dom’s MBA Degree Project ·      Lenoss Medical Plans to Go to Market Via Distributors Specializing in Products for Spinal Treatments ·      The Argument for Hospitals Is Reducing Risk and Simplifying the Process ·      FDA Approval Process Was Relatively Low-Burden, Human Cell and Tissue Product Pathway ·      Dom Messerli’s Immigrant Story ·      “Eventually, I was affected with the layoff. I was waiting for that day. The next day is when I started Lenoss Medical.” ·      “...I feel we can have a positive impact with these patients with osteoporosis and the spinal fractures. That drives me.”